
Star Imaging IPO Listing at 0% Premium at ₹142 Per Share
Updated: 18 Aug 2025 • 2:34 pm
Posted by:

Star Imaging IPO listing: The Star Imaging IPO was subscribed 5.67 times till its closing. In this subscription, 12.85 times were received by the qualified institutional buyers (QIBs) and 4.83 times by non-institutional investors (NIIs). The retail quota of the issue was subscribed to 31.23%. Before delving deeper into the topic, go through the details of the Star Imaging IPO.
Star Imaging
On the BSE and SME platform, Star Imaging Limited is listed at ₹142 per share at a premium of 0% against the issue price of ₹142 per share.
Star Imaging IPO Details
Star Imaging IPO: It is a bookbuilding IPO of ₹69.47 crore, comprising a fresh issue of 39.20 lakh shares and the offer for sale of 9.72 lakh shares. The issue will be listed on BSE and SME on its tentative listing date, 18th August 2025. The Star Imaging IPO date is fixed between 8th August 2025 and 12th August 2025. The face value of Star Imaging IPO shares stands at ₹10 per share, and the IPO price band is set at ₹142 per share.
| IPO Open Date | 8th August 2025 |
| IPO Close Date | 12th August 2025 |
| IPO Allotment Date | 12th August 2025 |
| Refund Initiation | 14th August 2025 |
| Issue Size | 48,92,000 shares(aggregating up to ₹69.47 Cr) |
| Fresh Issue | 34,40,000 shares(aggregating up to ₹48.85 Cr) |
| Offer for Sale | 9,72,000 shares of ₹10(aggregating up to ₹13.80 Cr) |
| Face Value | ₹10 per share |
| Lot Size | 1,000 Shares |
| Issue Price Band | ₹135 to ₹140 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE & SME |
| Listing Date | 18th August 2025 |
About Star Imaging IPO
Star Imaging & Path Lab Limited was incorporated in 2004. Star Imaging and Path Lab Limited is a healthcare company that operates in diagnostic imaging & pathology centres, offering various services, including MRI, CT, X-ray, Ultrasound, and laboratory services. The company’s focus is to provide high-quality healthcare accessible in semi-urban and suburban areas. Company. Star Imaging & Path Lab Limited has raised funds through its IPO for the expansion of healthcare services and to install modern equipment.
Star Imaging Limited Financials
The company’s financial analysis is essential before applying for the Star Imaging IPO. Look at the table to learn about Star Imaging Limited’s financials.
| Year Ended | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
| Assets | 98.16 | 81.64 | 61.23 |
| Revenue | 83.79 | 79.97 | 58.68 |
| Profit After Tax | 15.96 | 12.45 | 0.58 |
| EBITDA | 28.60 | 22.34 | 5.81 |
| Net Worth | 47.15 | 31.35 | 18.93 |
| Reserve and surplus | 33.65 | 29.85 | 17.43 |
| Total Borrowing | 32.73 | 30.64 | 26.56 |
Explanation
Star Imaging Limited’s revenue increased by 5% from ₹79.97 crores in March 2024 to ₹84.79 crores in March 2025. Moreover, the company’s PAT increased by 28% from ₹12.45 crores to ₹15.96 crores. Investors can analyse other relevant factors and make a decision accordingly.
Recent Articles
Max Healthcare Q1 Results FY26: Q1 PAT Rises 30.35% to ₹307.97 Crore; Revenue Up 31.41% YoY
Minda Corporation Q1 Results FY26: Q1 PAT Rises 1.73% to ₹65.31 Crore; Revenue Up 16.23% YoY
Bharat Dynamics Q1 Results FY26: Q1 PAT Rises 154.30% to ₹18.35 Crore; Revenue Up 29.69% YoY
Elitecon International Q1 Results FY26: Q1 PAT Rises 349.99% to ₹20.41 Crore; Revenue Up 301.98% YoY
Elgi Equipments Q1 Results FY26: Q1 PAT Rises 17.58% to ₹85.60 Crore; Revenue Up 8.19% YoY
Aavas Financier Q1 Results FY26: Q1 PAT Rises 10.41% to ₹139.23 Crore; Revenue Up 15.70% YoY
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
SBSJHVHSV Q4 FY26 Results: Q4 FY26 Results
Smiths and Founders Q4 FY26 Results: Q4 FY26 Results
Narmadesh Brass Industries Q4 FY26 Results: Q4 FY26 Results
Chandra Prabhu International Q4 FY26 Results: Q4 FY26 Results
Mega Nirman and Industries Q4 FY26 Results: Q4 FY26 Results
Popular this week
SBSJHVHSV Q4 FY26 Results: Q4 FY26 Results
Smiths and Founders Q4 FY26 Results: Q4 FY26 Results
Narmadesh Brass Industries Q4 FY26 Results: Q4 FY26 Results
Chandra Prabhu International Q4 FY26 Results: Q4 FY26 Results
Mega Nirman and Industries Q4 FY26 Results: Q4 FY26 Results

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





